Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
Nanjing, Jiangsu, China
Hospital in Nanjing
321 Zhongshan Rd, Gulou, Nanjing, Jiangsu, 210008
About Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Merck Sharp & Dohme LLC
4
Eli Lilly and Company
3
Takeda
2
AstraZeneca
1
Clinical Trials at Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
During the past decade, Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer
2016-12-05
2023-09-20
Active, not recruiting
463
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia
2016-07-01
2018-09-28
Terminated
1,722
A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer
2017-03-02
2021-04-12
Completed
440
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
2017-08-03
2028-07-18
Recruiting
402
Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.
2017-08-03
2020-08-14
Completed
215
A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus
2018-03-22
2020-03-18
Completed
536
Perioperative Enfortumab Vedotin (EV) Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle Invasive Bladder Cancer (MIBC) (MK-3475-B15/ KEYNOTE-B15 / EV-304)
2021-04-21
2026-12-23
Recruiting
784
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
2021-04-14
2026-10-29
Recruiting
1,653
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S"
#1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Eisai Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
According to Clinical.Site data, the most researched conditions in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S" are
"Alzheimer's Disease" (1 trials), "Breast Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S" in a lesser frequency.
Clinical Trials Intervention Types at Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
Most popular intervention types in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S" are "Drug" (10 trials), "Biological" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Pembrolizumab" (4 trials), "Belzutifan" (3 trials), "Lenvatinib" (2 trials) and "Vedolizumab IV" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
The vast majority of trials in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S" are
9 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
Currently, there are NaN active trials in "Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".